This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.
Company Profile:
HUTCHMED Ltd.
Market Cap (USD):
$2.87 B
Country:
Hong Kong
Sector:
HK Healthcare
Industry:
HK Biotechnology
Company Profile:
Translate Bio, Inc.
Market Cap (USD):
$2.82 B
(May 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
SpringWorks Therapeutics, Inc.
Market Cap (USD):
$2.76 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
MorphoSys AG
Market Cap (USD):
$2.74 B
Country:
Germany
Sector:
German Healthcare
Industry:
German Biotechnology
Company Profile:
Xenon Pharmaceuticals Inc.
Market Cap (USD):
$2.73 B
Country:
Canada
Sector:
Canadian Healthcare
Industry:
Canadian Biotechnology
Company Profile:
Geron Corporation
Market Cap (USD):
$2.69 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
ACADIA Pharmaceuticals Inc.
Market Cap (USD):
$2.67 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
ADMA Biologics, Inc.
Market Cap (USD):
$2.66 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Chinook Therapeutics, Inc.
Market Cap (USD):
$2.62 B
(July 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Yunnan Botanee Bio-Technology Group Co.LTD
Market Cap (USD):
$2.62 B
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
CymaBay Therapeutics, Inc.
Market Cap (USD):
$2.61 B
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Myovant Sciences Ltd.
Market Cap (USD):
$2.61 B
(Jan. 1, 2023)
Country:
United Kingdom
Sector:
UK Healthcare
Industry:
UK Biotechnology
Company Profile:
IDEAYA Biosciences, Inc.
Market Cap (USD):
$2.59 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
IVERIC bio, Inc.
Market Cap (USD):
$2.52 B
(Jan. 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Rhythm Pharmaceuticals, Inc.
Market Cap (USD):
$2.49 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Sinocelltech Group Ltd
Market Cap (USD):
$2.48 B
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Vaccibody AS
Market Cap (USD):
$2.45 B
(Dec. 1, 2021)
Country:
Norway
Sector:
Norway Healthcare
Industry:
Norway Biotechnology
Company Profile:
Agios Pharmaceuticals, Inc.
Market Cap (USD):
$2.42 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
BB Biotech AG
Market Cap (USD):
$2.40 B
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology
Company Profile:
RemeGen Co. Ltd
Market Cap (USD):
$2.40 B
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
PTC Therapeutics, Inc.
Market Cap (USD):
$2.37 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Boya Bio-pharmaceutical Group Co.,Ltd
Market Cap (USD):
$2.35 B
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Celldex Therapeutics, Inc.
Market Cap (USD):
$2.34 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Certara, Inc.
Market Cap (USD):
$2.29 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Vericel Corporation
Market Cap (USD):
$2.27 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
DaShenLin Pharmaceutical Group Co. Ltd
Market Cap (USD):
$2.22 B
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Oneness Biotech Co. Ltd
Market Cap (USD):
$2.22 B
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Deciphera Pharmaceuticals, Inc.
Market Cap (USD):
$2.21 B
(June 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Intellia Therapeutics, Inc.
Market Cap (USD):
$2.20 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
BrightGene Bio-Medical Technology Co. Ltd
Market Cap (USD):
$2.11 B
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology